Document is current
Any future updates will be listed below
-
Authors
Stautner, Bruno
Tkaczyszyn, Michał
Sorg, Anne
Suchocki, Tomasz
Jankowska, Ewa Anita
-
Funding
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 15 November 2024
Accepted: 17 October 2025
First Online: 23 October 2025
Declarations
:
: M.T. reports personal fees from Eidos Therapeutics and Alnylam Pharmaceuticals (as a sub-investigator in clinical trials); personal fees from Takeda; travel and accommodation expenses covered by Pfizer; and accommodation expenses covered by Polpharma, outside the submitted work. E.J. reports honoraria for lectures and participation in advisory boards from the following companies: AstraZeneca, Pfizer, Novo Nordisk, Boehringer Ingelheim, Bayer, Vifor Pharma, Pharmacosmos, Swixx Biopharma, Ewopharma, Novartis, Servier, Pfizer, Zoll, Takeda, Sanofi, Amicus, Medison.
